The DEA published this notice of proposed rule on December 4, 2020 and there is a 60-day comment period thereafter. Partial Filling of Prescriptions for Schedule II Controlled Substances, 85 Fed. Reg. 78,282 (proposed Dec. 4, 2020).
https://twitter.com/fdalawblog/status/1337394396421976065
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1306 [Docket No. DEA–469] RIN 1117–AB45
Partial Filling of Prescriptions for Schedule II Controlled Substances
AGENCY: Drug Enforcement Administration, Department of Justice. govinfo.gov/content/pkg/FR…
Drug Enforcement Administration
21 CFR Part 1306 [Docket No. DEA–469] RIN 1117–AB45
Partial Filling of Prescriptions for Schedule II Controlled Substances
AGENCY: Drug Enforcement Administration, Department of Justice. govinfo.gov/content/pkg/FR…
Federal Register Electronic comments must be submitted, and written comments must be postmarked, on or before February 2, 2021. ⤵️ federalregister.gov/documents/2020…
@threadreaderapp please compile
“DEA notes several “potential benefits” for proposed rule, lower costs, ⬇️ unused controlled medication ⬇️ potential for addiction, overdose and diversion.” In light of pending lawsuits regarding failing to fill scheduled RX, the question is... does the pain community agreee?
• • •
Missing some Tweet in this thread? You can try to
force a refresh
